New oral formulation for 5-HT4 agonists or antagonists

Details for Australian Patent Application No. 2006200048 (hide)

Owner Novartis AG

Inventors Engel, Gunter; Pfannkuche, Hans-Jurgen; Zuger, Othmar; De Bruijn, Karel; Thewissen, Michael; Vitzling, Christian

Agent Davies Collison Cave

Pub. Number AU-A-2006200048

Parent 2003248212

Filing date 6 January 2006

Wipo publication date 2 February 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

2 February 2006 Application Open to Public Inspection

  Published as AU-A-2006200048

2 February 2006 Complete Application Filed

26 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006200049-Biopsy instrument with improved needle penetration

2006200047-Data store for software application documents